Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"

ClinicalTrials.gov ID: NCT02671461

Public ClinicalTrials.gov record NCT02671461. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 1:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Placebo Controlled, Randomized, Double-Blind, Parallel-Arm Study to Evaluate Efficacy and Safety of BMS- 986141 For the Prevention of Recurrent Brain Infarction in Subjects Receiving Acetylsalicylic Acid (ASA) Following Acute Ischemic Stroke or Transient Ischemic Attack

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether BMS-986141 is effective in reducing the recurrence of stroke in people who recently had a stroke, or a transient ischemic attack (known as a TIA or "mini stroke") and are receiving acetylsalicylic acid (also known as aspirin or ASA) to treat the stroke or TIA.

Study identification

NCT ID
NCT02671461
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
16 participants

Conditions and interventions

Conditions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 25, 2016 (Actual)
Primary completion
Mar 31, 2017 (Actual)
Completion
Mar 31, 2017 (Actual)
Last update posted
Dec 14, 2018

2016 – 2017

United States locations

U.S. sites
27
U.S. states
18
U.S. cities
24
Facility City State ZIP Site status
Banner University Medical Ctr Phoenix Arizona 85006 —
Hoag Memorial Hospital Newport Beach California 92658 —
Local Institution Newark Delaware 19718 —
University Of Florida Gainesville Florida 32610 —
University Of Florida Hsc/Jacksonville Jacksonville Florida 32209 —
Florida Hospital Orlando Florida 32803 —
Intercoastal Medical Group Sarasota Florida 34239 —
Presence Saint Joseph Medical Center Joliet Illinois 64035 —
University Of Louisville Louisville Kentucky 40202 —
Local Institution Baltimore Maryland 21215 —
Tufts Medical Center Boston Massachusetts 02111 —
Boston Medical Center Boston Massachusetts 02118 —
St. Lukes Marion Bloch Neuroscience Institute Kansas City Missouri 64111 —
Advanced Neurology Specialists Great Falls Montana 59405 —
Local Institution Omaha Nebraska 68105 —
JFK Medical Center Edison New Jersey 08820-3947 —
Local Institution Chapel Hill North Carolina 27599 —
Duke University Medical Center Durham North Carolina 27710 —
Guilford Medical Associates, Pa Greensboro North Carolina 27405 —
Providence Portland Med Ctr Portland Oregon 97225 —
Providence St Vincent Medical Center Portland Oregon 97225 —
Oregon Health Science Univ Portland Oregon 97239 —
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104 —
York Hospital York Pennsylvania 17403 —
Medical University Of South Carolina Charleston South Carolina 29425 —
Local Institution Memphis Tennessee 38103 —
West Virginia University Morgantown West Virginia 26505 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02671461, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 14, 2018 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02671461 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →